Medica Group PLC
LSE:MGP
Medica Group PLC
Medica Group Plc engages in the provision of teleradiology reporting services. The company is headquartered in Hastings, Sussex and currently employs 207 full-time employees. The company went IPO on 2017-03-21. The firm provides outsourced interpretation and reporting of MRI (magnetic resonance imaging), CT (computerized tomography), ultrasound and plain film (x-ray) images. The firm operates through three geographic segments: UK, Ireland, and the US. The UK segment includes two primary services to hospital radiology departments: NightHawk and Elective. The NightHawk provides reporting services. The Elective offers cross-sectional reporting on MRI and CT scans, and plain film reporting on X-radiation (x -ray) images. The Ireland segment provides tele-radiology, managed services and a contract with the National Screening Service to deliver Ophthalmology services. The US segment provides radiology reporting to Pharma customers directly and indirectly via contract research organizations (CRO's). The company also provides diabetic retinopathy screening services.
Medica Group Plc engages in the provision of teleradiology reporting services. The company is headquartered in Hastings, Sussex and currently employs 207 full-time employees. The company went IPO on 2017-03-21. The firm provides outsourced interpretation and reporting of MRI (magnetic resonance imaging), CT (computerized tomography), ultrasound and plain film (x-ray) images. The firm operates through three geographic segments: UK, Ireland, and the US. The UK segment includes two primary services to hospital radiology departments: NightHawk and Elective. The NightHawk provides reporting services. The Elective offers cross-sectional reporting on MRI and CT scans, and plain film reporting on X-radiation (x -ray) images. The Ireland segment provides tele-radiology, managed services and a contract with the National Screening Service to deliver Ophthalmology services. The US segment provides radiology reporting to Pharma customers directly and indirectly via contract research organizations (CRO's). The company also provides diabetic retinopathy screening services.
